Sepsis remains the leading cause of death in most intensive care units. Advances in
understanding the immune response to sepsis provide the opportunity to develop more …

Abstract Background Recently novel Epstein–Barr virus (EBV) lymphoproliferative diseases
(LPDs) have been identified in non-immunocompromised hosts, both in Asia and Western …

Abstract EBV-associated T/NK–cell lymphoproliferative disease (T/NK-LPD) is defined as a
systemic illness characterized by clonal proliferation of EBV-infected T or NK cells. We …

The magnesium transporter 1 (MAGT1) is a critical regulator of basal intracellular free
magnesium (Mg2+) concentrations. Individuals with genetic deficiencies in MAGT1 have …

Chronic active EBV disease (CAEBV) is a lymphoproliferative disorder characterized by
markedly elevated levels of antibody to EBV or EBV DNA in the blood and EBV RNA or …

Purpose: We have recently reported EBV+ B-cell lymphoproliferative disorders (LPD)
occurring predominantly in elderly patients, which shared features of EBV+ B-cell …

Since the initial report of unusual manifestations possibly associated with chronic active
Epstein‐Barr virus (EBV) infection (CAEBV), nearly three decades have passed. During this …

Epstein-Barr virus (EBV) infection in humans is a major trigger of malignant and
nonmalignant B cell proliferations. CD27 is a co-stimulatory molecule of T cells, and …

BACKGROUND: CD27 is a lymphocyte costimulatory molecule that regulates T-cell, natural
killer (NK) cell, B-cell, and plasma cell function, survival, and differentiation. On the basis of …

Abstract Chronic active Epstein-Barr virus infection (CAEBV) is a high-mortality and high-
morbidity disease. To clarify the prognostic factors, a national survey was performed in …